Monday, February 16, 2026 | 03:10 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch
Sensex (    %)
                             
Nifty (    %)
                             
Nifty Midcap(    %)
                             
Nifty Smallcap(    %)
                             
Nifty Bank(    %)
                             
Nifty IT(    %)
                             
Home / Markets / Syncom Formulations (India) Ltd

Syncom Formulations (India) Share Price

Know More
BSENSE

₹13.44-0.58 (-4.14%)

03:02 PM, 16-Feb-2026

₹13.45-0.53 (-3.79%)

02:49 PM, 16-Feb-2026

BSE : 524470

NSE : SYNCOMF

Sector : Health care

ISIN Code : INE312C01025

  • BSE
  • NSE
  • 1D
  • 5D
  • 1M
  • 6M
  • 1Y
  • 2Y
  • 5Y
  • MAX

Last Updated: 16-Feb-2026 | 03:02 PM IST

Add to PortfolioAdd to Watchlist

Market Cap (₹ Cr)

1,263

Traded Value (₹ Cr)

0.23

Volume (Shares)

1,72,103

Face Value (₹)

1

52-Week High (₹)

23.46

52-Week High Date

28-May-2025

52-Week Low (₹)

11.52

52-Week Low Date

22-Jan-2026

All Time High (₹)

27.94

All Time High Date

10-Sep-2024

All Time Low (₹)

0.14

All Time Low Date

15-Jan-1998

Syncom Formulations (India) Ltd

Incorporated as a private limited Company in 1988 Syncom Formulations (India) Limited was converted into a public limited Company in June 1992. The Company in the Indian Pharmaceutical Industry represents synergistic combination of commitment and consistency. Syncom possesses the manufacturing strength in its own manufacturing set-up at Pithampur M...
Read More

Market News

More

Syncom Formul. Announcement

Submission of Press Clipping Related to extract of Un-Audited Financial Result for the Quarter and Nine months ended on 31st December 2025

Submission of Unaudited standalone and Consolidated Financials as an outcome of Board meeting held on 12th February 2026

Syncom Formulations India Ltd-has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 12/02/2026 inter alia to consider and approve Pursuant to Regulation 29(1) (a) of SEBI (LODR) Regulations 2015 read with SEBI (PIT) Regulations 2015 as amended from time to time we are pleased to inform that 5/2025-26 Meeting of the Board of Directors of the Company is scheduled to be held on Thursday the 12th day of February 2026 at 3:00 P.M. at the Corporate Office situated at 207 Saket Nagar Near Saket Club Indore (M.P.) 452018

Certificate for compliance of regulation 74(5) of the SEBI (Depositories and Participants) Regulation 2018 for the quarter ended 31st December 2025

Certificate for compliance of regulation 74(5) of the SEBI (Depositories and participants) regulation 2018 for the quarter ended 31st December 2025.

More

Syncom Formulations (India) Ltd - Key Fundamentals

PARAMETER VALUES
Market Cap (₹ Cr)

1,264

EPS - TTM (₹) [C]

0.73

P/E Ratio (X) [C]

18.42

Face Value (₹) 1
Latest Dividend (%)3.00
Latest Dividend Date 09-Sep-2022
Dividend Yield (%) -
Book Value Share (₹) [C]4.03
P/B Ratio (₹) [C]3.34

[*C] Consolidated [*S] Standalone

Funds Owning this Stock

Scheme Name Amount Invested (₹ Cr) No Of Shares Net Asset (%)
Data Not Found

Research Reports

DateBrokerActionPrices(₹) Report
Data Not Found

Stock Strength

Today's Low/High (₹)

13.34

13.93

Week Low/High (₹)

13.34

15.00

Month Low/High (₹)

11.65

15.00

Year Low/High (₹)

11.65

23.00

All time Low/High (₹)

0.14

28.00

Share Price Returns

Period BSENSE SENSEXNIFTY
1 Week-6.21%20.24%-0.97%-0.78%
1 Month3.86%32.54%-0.16%0.00%
3 Month-18.83%3.92%-1.55%-0.95%
6 Month-22.03%-0.81%3.29%4.20%
1 Year-23.45%-2.05%9.63%11.93%
3 Year88.90%140.98%35.77%42.30%

Company Info

Company Information

Chairman & Exec. Director : Kedarmal Bankda

ED / MD / Promoter : Vijay Bankda

Independent Non Exe. Director : Ruchi Jindal

Independent Non Exe. Director : Ritesh Kumar Lunkad

Independent Non Exe. Director : Ankit Jain

Chairman / Executive Director / WTD : ANKIT KEDARMAL BANKDA

Company Sec. & Compli. Officer : Vaishali Agrawal

Registered Office: 7 Niraj Indl Estate Andheri(E), Off Mahakali Caves Rd,Mumbai,Maharashtra-400093 Ph: 91-22-30887744

Email:finance@sfil.in; sfil87@syncomformulations.com

URL:http://www.syncomformulations.com

FAQs about Syncom Formulations (India) Ltd

1. What's the Syncom Formulations (India) Ltd share price today?
Syncom Formulations (India) Ltd share price was Rs 13.44 at 03:02 PM IST on 16th Feb 2026. Syncom Formulations (India) Ltd share price was down by 4.14% from the previous closing price of Rs 14.02. Syncom Formulations (India) Ltd share price trend:

  • Last 1 Month: Syncom Formulations (India) Ltd share price moved up by 3.86% on BSE.
  • Last 3 Months: Syncom Formulations (India) Ltd share price moved down by 18.83% on BSE.
  • Last 12 Months: Syncom Formulations (India) Ltd share price moved down by 23.45% on BSE.
  • Last 3 Years: Syncom Formulations (India) Ltd share price moved up by 88.90% on BSE.


2. How can I quickly analyse the performance of the Syncom Formulations (India) Ltd stock?
The performance of the Syncom Formulations (India) Ltd stock can be quickly analysed on the following metrics:

  • The stock's PE is 18.42
  • Price to book value ratio is 3.34
  • The EPS (trailing 12 months) of the Syncom Formulations (India) Ltd stock is Rs 0.73


3. What is the market cap of Syncom Formulations (India) Ltd?
Syncom Formulations (India) Ltd has a market capitalisation of Rs 1,263 crore.


4. What is Syncom Formulations (India) Ltd's 52-week high/low share price?
The Syncom Formulations (India) Ltd’s 52-week high share price is Rs 23.46 and 52-week low share price is Rs 11.52.


5. Is the Syncom Formulations (India) Ltd profitable?
On a consolidated basis, Syncom Formulations (India) Ltd reported a profit of Rs 18.91 crore on a total income of Rs 120.64 crore for the quarter ended 2025.


6. Which are Syncom Formulations (India) Ltd’s peers in the Health care sector?
Syncom Formulations (India) Ltd’s top 5 peers in the Health care sector are Kwality Pharma, NGL Fine Chem, Hester Bios, Syncom Formul., Lincoln Pharma., Ind-Swift Labs., Jagsonpal Pharma.


7. Who owns how much in Syncom Formulations (India) Ltd?
Key changes to the Syncom Formulations (India) Ltd shareholding are as follows:

  • Promoter holding in Syncom Formulations (India) Ltd has gone up to 50.57 per cent as of Dec 2025 from 50.57 per cent as of Mar 2025.